Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001179110-15-009306
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-08 16:01:35
Reporting Period:
2015-06-04
Filing Date:
2015-06-08
Accepted Time:
2015-06-08 16:01:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1360886 Osiris Therapeutics Inc. OSIR Biological Products, (No Disgnostic Substances) (2836) 710881115
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1625312 Ivan Gregory Law C/o Osiris Therapeutics, Inc.
7015 Albert Einstein Drive
Columbia MD 21046
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-04 100 $18.83 100 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Incentive Stock Option (right to buy) $13.05 2014-11-17 2024-11-17 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-11-17 20,000 20,000 Direct